Home / Cancer and immune system / Tazemetostat
ATC L01XX72 · Other Antineoplastic Agents · updated 2 Nov 2026
Tazemetostat shortage
As of 2 Nov 2026, Tazemetostat has a reported shortage in 1 of the 16 countries we track (United States), covering 1 product from 1 company.
Is there a Tazemetostat shortage?
Yes. As of 2 Nov 2026, Tazemetostat is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Ipsen IPN · Euronext Paris
Compared with similar medicines
ATC group L01XX · Other Antineoplastic AgentsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Tazverik, Tablet, 200 mg (NDC 72607-100-00) discontinuation | Epizyme, Inc. (An Ipsen Company) | 27 Mar 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Tazemetostat shortage?
Yes. As of 2 Nov 2026, Tazemetostat is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
When will Tazemetostat be back in stock?
No return date has been given; United States: no date given. These are company estimates reported to each authority.
Why is Tazemetostat in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Tazemetostat shortages?
Ipsen.